vs
ABEONA THERAPEUTICS INC.（ABEO）与爱齐科技（ALGN）财务数据对比。点击上方公司名可切换其他公司
爱齐科技自由现金流更多（$187.3M vs $-23.7M）
Abeona Therapeutics是一家临床阶段生物制药公司，专注于研发针对致命罕见遗传病的创新基因与细胞疗法，其管线覆盖多种未被满足的临床需求，主要为北美、欧洲地区缺乏有效治疗方案的患者群体服务。
爱齐科技是一家全球知名医疗设备企业，主营设计、生产及销售隐适美透明矫治器、iTero口内扫描仪及配套服务，客户覆盖正畸医师、全科牙医，面向修复、美容牙科领域，业务分为透明矫治器、扫描仪及服务两大板块，可满足青少年等不同群体的正畸需求
ABEO vs ALGN — 直观对比
营收规模更大
ALGN
是对方的Infinity倍
$0
自由现金流更多
ALGN
多$211.0M
$-23.7M
损益表 — Q3 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $0 | $1.0B |
| 净利润 | $-5.2M | $135.8M |
| 毛利率 | — | 65.3% |
| 营业利润率 | — | 14.8% |
| 净利率 | — | 13.0% |
| 营收同比 | — | 5.3% |
| 净利润同比 | 82.9% | 30.8% |
| 每股收益（稀释后） | $-0.10 | $1.88 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABEOALGN
| Q4 25 | — | $1.0B | ||
| Q3 25 | $0 | $995.7M | ||
| Q2 25 | $400.0K | $1.0B | ||
| Q1 25 | — | $979.3M | ||
| Q4 24 | — | $995.2M | ||
| Q3 24 | — | $977.9M | ||
| Q2 24 | — | $1.0B | ||
| Q1 24 | — | $997.4M |
净利润ABEOALGN
| Q4 25 | — | $135.8M | ||
| Q3 25 | $-5.2M | $56.8M | ||
| Q2 25 | $108.8M | $124.6M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $103.8M | ||
| Q3 24 | — | $116.0M | ||
| Q2 24 | — | $96.6M | ||
| Q1 24 | — | $105.0M |
毛利率ABEOALGN
| Q4 25 | — | 65.3% | ||
| Q3 25 | — | 64.2% | ||
| Q2 25 | — | 69.9% | ||
| Q1 25 | — | 69.5% | ||
| Q4 24 | — | 70.0% | ||
| Q3 24 | — | 69.7% | ||
| Q2 24 | — | 70.3% | ||
| Q1 24 | — | 70.0% |
营业利润率ABEOALGN
| Q4 25 | — | 14.8% | ||
| Q3 25 | — | 9.7% | ||
| Q2 25 | -5698.0% | 16.1% | ||
| Q1 25 | — | 13.4% | ||
| Q4 24 | — | 14.5% | ||
| Q3 24 | — | 16.6% | ||
| Q2 24 | — | 14.3% | ||
| Q1 24 | — | 15.5% |
净利率ABEOALGN
| Q4 25 | — | 13.0% | ||
| Q3 25 | — | 5.7% | ||
| Q2 25 | 27208.3% | 12.3% | ||
| Q1 25 | — | 9.5% | ||
| Q4 24 | — | 10.4% | ||
| Q3 24 | — | 11.9% | ||
| Q2 24 | — | 9.4% | ||
| Q1 24 | — | 10.5% |
每股收益（稀释后）ABEOALGN
| Q4 25 | — | $1.88 | ||
| Q3 25 | $-0.10 | $0.78 | ||
| Q2 25 | $1.71 | $1.72 | ||
| Q1 25 | — | $1.27 | ||
| Q4 24 | — | $1.40 | ||
| Q3 24 | — | $1.55 | ||
| Q2 24 | — | $1.28 | ||
| Q1 24 | — | $1.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $207.1M | $1.1B |
| 总债务越低越好 | $19.8M | — |
| 股东权益账面价值 | $171.2M | $4.0B |
| 总资产 | $231.1M | $6.2B |
| 负债/权益比越低杠杆越低 | 0.12× | — |
8季度趋势，按日历期对齐
现金及短期投资ABEOALGN
| Q4 25 | — | $1.1B | ||
| Q3 25 | $207.1M | $1.0B | ||
| Q2 25 | $225.5M | $901.2M | ||
| Q1 25 | — | $873.0M | ||
| Q4 24 | — | $1.0B | ||
| Q3 24 | — | $1.0B | ||
| Q2 24 | — | $761.4M | ||
| Q1 24 | — | $865.8M |
总债务ABEOALGN
| Q4 25 | — | — | ||
| Q3 25 | $19.8M | — | ||
| Q2 25 | $19.6M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ABEOALGN
| Q4 25 | — | $4.0B | ||
| Q3 25 | $171.2M | $4.0B | ||
| Q2 25 | $163.6M | $3.9B | ||
| Q1 25 | — | $3.8B | ||
| Q4 24 | — | $3.9B | ||
| Q3 24 | — | $3.9B | ||
| Q2 24 | — | $3.8B | ||
| Q1 24 | — | $3.8B |
总资产ABEOALGN
| Q4 25 | — | $6.2B | ||
| Q3 25 | $231.1M | $6.2B | ||
| Q2 25 | $246.2M | $6.2B | ||
| Q1 25 | — | $6.1B | ||
| Q4 24 | — | $6.2B | ||
| Q3 24 | — | $6.4B | ||
| Q2 24 | — | $6.2B | ||
| Q1 24 | — | $6.2B |
负债/权益比ABEOALGN
| Q4 25 | — | — | ||
| Q3 25 | 0.12× | — | ||
| Q2 25 | 0.12× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-21.2M | $223.2M |
| 自由现金流经营现金流 - 资本支出 | $-23.7M | $187.3M |
| 自由现金流率自由现金流/营收 | — | 17.9% |
| 资本支出强度资本支出/营收 | — | 3.4% |
| 现金转化率经营现金流/净利润 | — | 1.64× |
| 过去12个月自由现金流最近4个季度 | — | $490.8M |
8季度趋势，按日历期对齐
经营现金流ABEOALGN
| Q4 25 | — | $223.2M | ||
| Q3 25 | $-21.2M | $188.7M | ||
| Q2 25 | $-18.8M | $128.7M | ||
| Q1 25 | — | $52.7M | ||
| Q4 24 | — | $286.1M | ||
| Q3 24 | — | $263.7M | ||
| Q2 24 | — | $159.8M | ||
| Q1 24 | — | $28.7M |
自由现金流ABEOALGN
| Q4 25 | — | $187.3M | ||
| Q3 25 | $-23.7M | $169.0M | ||
| Q2 25 | $-21.7M | $107.2M | ||
| Q1 25 | — | $27.4M | ||
| Q4 24 | — | $263.1M | ||
| Q3 24 | — | $233.9M | ||
| Q2 24 | — | $106.4M | ||
| Q1 24 | — | $19.3M |
自由现金流率ABEOALGN
| Q4 25 | — | 17.9% | ||
| Q3 25 | — | 17.0% | ||
| Q2 25 | -5421.3% | 10.6% | ||
| Q1 25 | — | 2.8% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 23.9% | ||
| Q2 24 | — | 10.3% | ||
| Q1 24 | — | 1.9% |
资本支出强度ABEOALGN
| Q4 25 | — | 3.4% | ||
| Q3 25 | — | 2.0% | ||
| Q2 25 | 725.3% | 2.1% | ||
| Q1 25 | — | 2.6% | ||
| Q4 24 | — | 2.3% | ||
| Q3 24 | — | 3.0% | ||
| Q2 24 | — | 5.2% | ||
| Q1 24 | — | 0.9% |
现金转化率ABEOALGN
| Q4 25 | — | 1.64× | ||
| Q3 25 | — | 3.33× | ||
| Q2 25 | -0.17× | 1.03× | ||
| Q1 25 | — | 0.57× | ||
| Q4 24 | — | 2.76× | ||
| Q3 24 | — | 2.27× | ||
| Q2 24 | — | 1.66× | ||
| Q1 24 | — | 0.27× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
